BILL Holdings BILL 深 滬
等待開盤 09-17 09:30:00 美东时间
49.00
-0.960
-1.92%
華盛通- 最 高49.55
- 今 開49.18
- 成交量 192.96万股
- 最 低 48.31
- 昨 收 49.96
- 總市值 41.79亿
- 52周最高 57.21
- 市盈率 靜 --
- 換手率 2.26%
- 52周最低 31.41
- 委 比 73.15%
- 總股本 8527.68万
- 歷史最高 348.495
- 量 比 1.12
- 振 幅 2.48%
- 歷史最低 23.61
- 每 手 1
- 風險率 6.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $52
Truist Securities analyst Matthew Coad maintains BILL Holdings (NYSE:BILL) with a Hold and raises the price target from $44 to $52.
09-01 23:55
美股大行评级 | 瑞杰金融维持英伟达"强力买入"评级，目标价从330美元升至352美元；瑞穗下调美光科技目标价从1375美元降至1300美元
今日重点评级关注：摩根大通：维持Ultragenyx Pharmaceutical"超配"评级，目标价从75美元升至80美元；瑞杰金融：维持英伟达"强力买入"评级，目标价从330美元升至352美元
08-26 08:37
美股大行评级 | 塔吉特获13家大行上调目标价；Moderna携手默沙东齐获大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持Ultragenyx Pharmaceutical"超配"评级，目标价从96美元升至103美元；Canaccord Genuity：维持Ultragenyx Pharmaceutical"买入"评级，目标价从81美元升至83美元
08-21 11:40
财报速睇 | BILL Holdings 2026财年年度营收16.53亿美元，同比增长13.0%；归母净利润亏损0.11亿美元，由盈转亏
华盛资讯8月21日讯，BILL Holdings公布2026财年年度业绩，公司年度营收16.53亿美元，同比增长13.0%，归母净利润亏损0.11亿美元，由盈转亏。
08-21 04:20
Bill Holdings Shares Climb on Strong Q4 Report: Details
Bill Holdings Inc. (NYSE:BILL) posted its fourth-quarter results after Wednesday’s closing bell, beating estimates on the top and bottom lines. Here’s a look at the details inside the report. BILL stock is moving. Watch the price action here. Bill Q4 Details Bill Holdings reported quarterly ea...
08-20 04:38
财报速睇 | BILL Holdings 2026财年Q2营收4.36亿美元，同比增长13.8%；归母净利润亏损0.18亿美元，同比亏损扩大157.1%
华盛资讯8月20日讯，BILL Holdings公布2026财年Q2业绩，公司Q2营收4.36亿美元，同比增长13.8%，归母净利润亏损0.18亿美元，同比亏损扩大157.1%。
08-20 04:19
BILL Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 adjusted EPS guidance above estimates. Also, the company issued FY27 adjusted EPS guidance above estimates.
BILL Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 adjusted EPS guidance above estimates. Also, the company issued FY27 adjusted EPS guidance above estimates.
08-20 04:05
BILL Holdings Sees FY2027 Adj EPS $3.56-$3.79 vs $3.35 Est; Sees Sales $1.807B-$1.857B vs $1.848B Est
BILL Holdings (NYSE:BILL) is looking for FY2027 Adj EPS of $3.56-$3.79 vs $3.35 analyst estimate. sees sales of $1.807 billion-$1.857 billion vs $1.848 billion analyst estimate.
08-20 04:03
BILL Holdings Q4 Adj. EPS $0.84 Beats $0.70 Estimate, Sales $436.186M Beat $430.553M Estimate
BILL Holdings (NYSE:BILL) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.70 by 18.31 percent. This is a 58.49 percent increase over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $436.186 million whi...
08-20 04:01
